BBC Among Health Care ETFs
End-of-day Nov 17, 2026 · 33 Health care ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.7% | −10.5% | −1.6% | −28.3% | +4.2% | +26.3% | +138.5% | −10.9% | +133.4% | +57.5% |
| Peer average | −1.2% | −4.0% | +2.1% | −3.2% | +18.2% | +23.3% | +71.2% | +24.1% | +174.3% | — |
| S&P 500 · VOO | −1.0% | −2.4% | −4.5% | −4.5% | +8.3% | +10.2% | +72.7% | +68.0% | +305.1% | — |
$24 of every $1,000 in BBC is Kodiak
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | KODKodiak Sciences | Healthcare | 2.42% | $241.57 | 7,839 | $790K |
| 2 | XNCRXencor | Healthcare | 2.34% | $234.49 | 22K | $766K |
| 3 | TRAXFirst Tracks Biotherapeutics | Healthcare | 2.16% | $215.58 | 15K | $705K |
| 4 | REPLReplimune Group | Healthcare | 1.97% | $196.92 | 30K | $644K |
| 5 | ABCLAbCellera Biologics | Healthcare | 1.73% | $173.32 | 51K | $567K |
| 6 | AMLXAmylyx Pharmaceuticals | Healthcare | 1.56% | $155.62 | 18K | $509K |
| 7 | VRDNViridian Therapeutics | Healthcare | 1.49% | $148.87 | 16K | $487K |
| 8 | SGPSpyGlass Pharma | Healthcare | 1.43% | $142.80 | 14K | $467K |
| 9 | LBRXLB Pharmaceuticals | Healthcare | 1.24% | $123.55 | 9,394 | $404K |
| 10 | PRMEPrime Medicine | Healthcare | 1.23% | $123.32 | 96K | $403K |
| 11 | MBXMBX Biosciences | Healthcare | 1.22% | $122.19 | 7,519 | $399K |
| 12 | KYMRKymera Therapeutics | Healthcare | 1.19% | $119.24 | 3,097 | $390K |
| 13 | CGONCG Oncology | Healthcare | 1.16% | $116.33 | 4,485 | $380K |
| 14 | ORKAOruka Therapeutics | Healthcare | 1.16% | $115.98 | 3,820 | $379K |
| 15 | ZBIOZenas Biopharma | Healthcare | 1.15% | $115.19 | 13K | $377K |
of the $112B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | KOD | Kodiak Sciences | 2.42% |
| 2 | XNCR | Xencor | 2.34% |
| 3 | TRAX | First Tracks Biotherapeutics | 2.16% |
| 4 | REPL | Replimune Group | 1.97% |
| 5 | ABCL | AbCellera Biologics | 1.73% |
| 6 | AMLX | Amylyx Pharmaceuticals | 1.56% |
| 7 | VRDN | Viridian Therapeutics | 1.49% |
| 8 | SGP | SpyGlass Pharma | 1.43% |
| 9 | LBRX | LB Pharmaceuticals | 1.24% |
| 10 | PRME | Prime Medicine | 1.23% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 22, 2025 | Dec 29, 2025 | $0.66 |
| Dec 20, 2024 | Dec 27, 2024 | $0.24 |
| Dec 20, 2023 | Dec 29, 2023 | $0.0823 |
| Dec 20, 2017 | Dec 27, 2017 | $0.30 |
| Dec 21, 2015 | Dec 29, 2015 | $0.15 |